Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
3,207,826
-
Share change
-
+161,798
-
Total reported value
-
$205,589,007
-
Put/Call ratio
-
68%
-
Price per share
-
$64.18
-
Number of holders
-
48
-
Value change
-
+$10,968,047
-
Number of buys
-
14
-
Number of sells
-
18
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2019
As of 31 Dec 2019 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,207,826 shares of stock of the company.
Largest 10 holders included CREDIT SUISSE AG/, BNP PARIBAS ARBITRAGE, SA, GOLDMAN SACHS GROUP INC, CLS Investments, LLC, Orion Portfolio Solutions, LLC, Western Wealth Management, LLC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, and ROYAL BANK OF CANADA.
This table shows 48 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.